DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/16461| Title: | Non Alcoholic Fatty Liver Disease Frequently Asked Questions (FAQ) in 2021 |
| Other Titles: | La stéatopathie métabolique FAQ en 2021 |
| Authors: | Taharboucht, S. |
| Keywords: | Nonalcoholic fatty liver disease, non-invasive diagnosis, NASH Stéatopathie métabolique, diagnostic non invasif, NASH |
| Issue Date: | Jul-2021 |
| Publisher: | Faculte de Medecine, Universite Blida 1 |
| Abstract: | The Non-Alcoholic Fatty Liver Disease has become in a space of a few years an increasingly frequent pathology in all types of population (general and specific). It is one of the leading causes of chronic liver disease and liver transplants worldwide. Through this article, we will address the most frequent questions relating to this pathology and their answers according to the latest scientific advances in 2021 RÉSUMÉ La stéatopathie métabolique est devenue en espace de quelques années une pathologie de plus en plus fréquente touchant tout type de population (générale et spécifique). Elle est une des premières causes d’hépatopathies chroniques et de transplantations hépatiques dans le monde. A travers cet article, nous aborderons les plus fréquentes questions relatives à cette pathologie et leurs réponses selon les dernières avancées scientifiques de 2021. |
| URI: | https://di.univ-blida.dz/jspui/handle/123456789/16461 |
| ISSN: | 2676-1858 |
| Appears in Collections: | revue |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.